Literature DB >> 28594651

miR-4728-3p Functions as a Tumor Suppressor in Ulcerative Colitis-associated Colorectal Neoplasia Through Regulation of Focal Adhesion Signaling.

Joel Pekow1, Alan L Hutchison, Katherine Meckel, Kymberly Harrington, Zifeng Deng, Nitya Talasila, David T Rubin, Stephen B Hanauer, Roger Hurst, Konstantin Umanskiy, Alessandro Fichera, John Hart, Aaron R Dinner, Marc Bissonnette.   

Abstract

BACKGROUND: As mechanisms of neoplasia in patients with ulcerative colitis (UC) remain poorly understood, we sought to identify pathways of carcinogenesis in this high-risk population.
METHODS: MicroRNA (miRNA) and mRNA expression was examined in nondysplastic rectosigmoid mucosa from UC patients with (n = 19) or without remote colon neoplasia (n = 23). We developed a method to identify miRNA-regulated pathways based on differentially expressed miRNAs and their putative mRNAs targets in the same samples. One key pathway identified in the analysis, miR-4728-3p regulation of focal adhesion signaling was further evaluated in vitro and through examination of expression in UC-cancers.
RESULTS: There were 101 significantly up-regulated and 98 down-regulated miRNAs (adjusted P < 0.05) in the rectal mucosa of UC patients harboring proximal neoplasia. Bioinformatic analysis identified miR-4728-3p as a regulator of 3 proteins involved in focal adhesion signaling, CAV1, THBS2, and COL1A2. Real-time PCR validated down-regulation of miR-4728-3p in nondysplastic tissue remote from UC-neoplasia and in UC-associated colon cancers. miR-4728-3p transfection into colon cancer cells down-regulated expression levels and decreased luciferase activities in cells expressing a wild type 3' untranslated region compared with a mutant 3' untranslated region for all 3 genes. Exogenous transfected miR-4728-3p also delayed wound healing and decreased formation of focal adhesion complexes.
CONCLUSIONS: Patients with long-standing UC who harbor neoplasia can be identified based on miRNA and mRNA profiles in nondysplastic tissue. Using a method to analyze miRNA and mRNA expression from the same tissues, we identified that miR-4728-3p is likely an important tumor suppressor in UC-associated colon carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28594651      PMCID: PMC5535754          DOI: 10.1097/MIB.0000000000001104

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  39 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Sample size determination in microarray experiments for class comparison and prognostic classification.

Authors:  Kevin Dobbin; Richard Simon
Journal:  Biostatistics       Date:  2005-01       Impact factor: 5.899

3.  Rho proteins play a critical role in cell migration during the early phase of mucosal restitution.

Authors:  M F Santos; S A McCormack; Z Guo; J Okolicany; Y Zheng; L R Johnson; G Tigyi
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

4.  IL13 Receptor α2 Signaling Requires a Scaffold Protein, FAM120A, to Activate the FAK and PI3K Pathways in Colon Cancer Metastasis.

Authors:  Rubén A Bartolomé; Irene García-Palmero; Sofía Torres; María López-Lucendo; Irina V Balyasnikova; J Ignacio Casal
Journal:  Cancer Res       Date:  2015-04-20       Impact factor: 12.701

5.  Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis.

Authors:  T A Brentnall; D A Crispin; P S Rabinovitch; R C Haggitt; C E Rubin; A C Stevens; G C Burmer
Journal:  Gastroenterology       Date:  1994-08       Impact factor: 22.682

6.  MiR-4728-3p could act as a marker of HER2 status.

Authors:  Hai Li; Xin Zhou; Jun Zhu; Wenfang Cheng; Wei Zhu; Yongqian Shu; Ping Liu
Journal:  Cancer Biomark       Date:  2015       Impact factor: 4.388

7.  miR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenes.

Authors:  Joel R Pekow; Urszula Dougherty; Reba Mustafi; Hongyan Zhu; Masha Kocherginsky; David T Rubin; Stephen B Hanauer; John Hart; Eugene B Chang; Alessandro Fichera; Loren J Joseph; Marc Bissonnette
Journal:  Inflamm Bowel Dis       Date:  2011-05-06       Impact factor: 5.325

8.  Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.

Authors:  Matthew Rutter; Brian Saunders; Kay Wilkinson; Steve Rumbles; Gillian Schofield; Michael Kamm; Christopher Williams; Ashley Price; Ian Talbot; Alastair Forbes
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

Review 9.  An intracellular signal pathway that regulates cancer cell adhesion in response to extracellular forces.

Authors:  Marc D Basson
Journal:  Cancer Res       Date:  2008-01-01       Impact factor: 12.701

10.  A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling.

Authors:  Y Wei; X Yang; Q Liu; J A Wilkins; H A Chapman
Journal:  J Cell Biol       Date:  1999-03-22       Impact factor: 10.539

View more
  12 in total

1.  Identification of hub genes and pathways in colitis-associated colon cancer by integrated bioinformatic analysis.

Authors:  Yongming Huang; Xiaoyuan Zhang; Yansen Li; Jie Yao
Journal:  BMC Genom Data       Date:  2022-06-22

2.  Upregulation of BMI1-suppressor miRNAs (miR-200c, miR-203) during terminal differentiation of colon epithelial cells.

Authors:  Shigeo Hisamori; Junko Mukohyama; Sanjay Koul; Takanori Hayashi; Piero Dalerba; Yohei Shimono; Michael Evan Rothenberg; Masao Maeda; Taichi Isobe; Luis Enrique Valencia Salazar; Xin Qian; Darius Michael Johnston; Dalong Qian; Kaiqin Lao; Naoya Asai; Yoshihiro Kakeji; Vincenzo Alessandro Gennarino; Debashis Sahoo
Journal:  J Gastroenterol       Date:  2022-03-04       Impact factor: 6.772

Review 3.  MicroRNAs in intestinal barrier function, inflammatory bowel disease and related cancers-their effects and therapeutic potentials.

Authors:  Esmerina Tili; Jean-Jacques Michaille; Victoria Piurowski; Brooke Rigot; Carlo M Croce
Journal:  Curr Opin Pharmacol       Date:  2017-11-15       Impact factor: 5.547

Review 4.  Aflatoxin B1 and M1: Biological Properties and Their Involvement in Cancer Development.

Authors:  Silvia Marchese; Andrea Polo; Andrea Ariano; Salvatore Velotto; Susan Costantini; Lorella Severino
Journal:  Toxins (Basel)       Date:  2018-05-24       Impact factor: 4.546

5.  Predicting MicroRNA Target Genes and Identifying Hub Genes in IIA Stage Colon Cancer Patients Using Bioinformatics Analysis.

Authors:  Zhiyong Dong; Wei Lin; Stacy A Kujawa; Shike Wu; Cunchuan Wang
Journal:  Biomed Res Int       Date:  2019-02-07       Impact factor: 3.411

6.  Refinement of breast cancer molecular classification by miRNA expression profiles.

Authors:  Rolf Søkilde; Helena Persson; Anna Ehinger; Anna Chiara Pirona; Mårten Fernö; Cecilia Hegardt; Christer Larsson; Niklas Loman; Martin Malmberg; Lisa Rydén; Lao Saal; Åke Borg; Johan Vallon-Christerson; Carlos Rovira
Journal:  BMC Genomics       Date:  2019-06-17       Impact factor: 3.969

Review 7.  MicroRNAs in Ocular Infection.

Authors:  Shunbin Xu; Linda D Hazlett
Journal:  Microorganisms       Date:  2019-09-17

8.  TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2.

Authors:  You Shuai; Zhonghua Ma; Weitao Liu; Tao Yu; Changsheng Yan; Hua Jiang; Shengwang Tian; Tongpeng Xu; Yongqian Shu
Journal:  Mol Cancer       Date:  2020-01-10       Impact factor: 27.401

9.  Increased mucosal expression of miR-215 precedes the development of neoplasia in patients with long-standing ulcerative colitis.

Authors:  Joel Pekow; Katherine Meckel; Urszula Dougherty; Haider I Haider; Zifeng Deng; John Hart; David T Rubin; Marc Bissonnette
Journal:  Oncotarget       Date:  2018-04-17

10.  MicroRNA-4728 serves as a suppressor and antagonist of oncogenic MAPK in Burkitt lymphoma.

Authors:  Wei Wang; Peng Lin; Haiying Yao; Xi Jia; Jirui Sun; Lin Feng
Journal:  Saudi J Biol Sci       Date:  2018-05-07       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.